Title | Type | SJR | H index | Total Docs. (2001) | Total Docs. (3years) | Total Refs. (2001) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2001) | %Female (2001) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Advances in Cancer Research | journal | 6.501 Q1 | 109 | 26 | 41 | 4927 | 557 | 41 | 11.22 | 189.50 | 22.00 | |
2 | Current Problems in Cancer | journal | 0.188 Q3 | 47 | 11 | 41 | 1447 | 21 | 35 | 0.36 | 131.55 | 25.00 | |
3 | NTP Technical Report on the Toxicology and Carcinogenesis Studies Series | book series | 9 | 8 | 28 | 1020 | 1 | 28 | 0.05 | 127.50 | 15.71 | ||
4 | Current Cancer Drug Targets | journal | 103 | 16 | 0 | 1772 | 0 | 0 | 0.00 | 110.75 | 21.43 | ||
5 | Blood Reviews | journal | 0.782 Q2 | 112 | 19 | 63 | 2034 | 193 | 63 | 3.00 | 107.05 | 30.00 | |
6 | Cancer Treatment and Research | journal | 0.363 Q3 | 65 | 73 | 139 | 7349 | 93 | 139 | 0.75 | 100.67 | 28.80 | |
7 | Biochimica et Biophysica Acta - Reviews on Cancer | journal | 4.128 Q1 | 159 | 25 | 92 | 2259 | 622 | 92 | 5.93 | 90.36 | 32.81 | |
8 | Cancer and Metastasis Reviews | journal | 2.115 Q1 | 167 | 32 | 123 | 2800 | 604 | 122 | 3.84 | 87.50 | 27.47 | |
9 | Best Practice and Research in Clinical Haematology | journal | 0.585 Q2 | 81 | 49 | 139 | 3957 | 253 | 128 | 1.46 | 80.76 | 30.59 | |
10 | Hematology/Oncology Clinics of North America | journal | 0.858 Q1 | 95 | 64 | 238 | 5132 | 620 | 221 | 2.10 | 80.19 | 23.68 | |
11 | Drug Resistance Updates | journal | 0.727 Q2 | 132 | 42 | 155 | 3286 | 324 | 146 | 1.77 | 78.24 | 30.12 | |
12 | Endocrine-Related Cancer | journal | 1.282 Q1 | 146 | 30 | 113 | 2301 | 380 | 107 | 4.00 | 76.70 | 34.44 | |
13 | Journal of Mammary Gland Biology and Neoplasia | journal | 1.449 Q1 | 112 | 42 | 117 | 3151 | 392 | 112 | 3.06 | 75.02 | 44.68 | |
14 | Critical Reviews in Oncology/Hematology | journal | 0.601 Q2 | 144 | 93 | 182 | 6941 | 331 | 173 | 2.00 | 74.63 | 36.06 | |
15 | Surgical Oncology | journal | 0.393 Q2 | 75 | 13 | 75 | 794 | 65 | 69 | 0.79 | 61.08 | 14.71 | |
16 | Cancer Cell International | journal | 80 | 3 | 0 | 177 | 0 | 0 | 0.00 | 59.00 | 40.00 | ||
17 | Molecular Cancer Research | journal | 2.769 Q1 | 153 | 66 | 255 | 3826 | 1148 | 255 | 3.51 | 57.97 | 36.36 | |
18 | Seminars in Radiation Oncology | journal | 1.263 Q1 | 103 | 39 | 135 | 2168 | 421 | 125 | 2.96 | 55.59 | 29.27 | |
19 | Surgical Oncology Clinics of North America | journal | 0.765 Q2 | 68 | 66 | 185 | 3493 | 284 | 150 | 1.10 | 52.92 | 18.49 | |
20 | Cancer Investigation | journal | 0.666 Q2 | 93 | 100 | 296 | 5254 | 453 | 254 | 1.50 | 52.54 | 26.80 | |
21 | Clinical and Experimental Metastasis | journal | 0.954 Q1 | 109 | 1 | 266 | 49 | 509 | 266 | 1.65 | 49.00 | 28.57 | |
22 | CME Journal of Gynecologic Oncology | journal | 0.113 Q4 | 8 | 54 | 173 | 2619 | 17 | 154 | 0.13 | 48.50 | 19.44 | |
23 | Molecular Cancer Therapeutics | journal | 199 | 17 | 0 | 801 | 0 | 0 | 0.00 | 47.12 | 37.50 | ||
24 | Revisiones en Cancer | journal | 0.112 Q4 | 2 | 19 | 40 | 878 | 2 | 40 | 0.05 | 46.21 | 28.00 | |
25 | Hematological Oncology | journal | 0.323 Q3 | 54 | 13 | 47 | 591 | 53 | 47 | 1.21 | 45.46 | 33.33 | |
26 | Expert Review of Anticancer Therapy | journal | 85 | 89 | 0 | 4041 | 0 | 0 | 0.00 | 45.40 | 24.81 | ||
27 | Journal of Neuro-Oncology | journal | 0.574 Q2 | 135 | 143 | 462 | 6399 | 776 | 452 | 1.53 | 44.75 | 25.81 | |
28 | Acta Oncologica | journal | 0.523 Q2 | 119 | 118 | 427 | 5127 | 570 | 401 | 1.34 | 43.45 | 26.98 | |
29 | Breast Disease | journal | 0.183 Q3 | 36 | 39 | 58 | 1637 | 25 | 50 | 0.62 | 41.97 | 50.67 | |
30 | Current Opinion in Oncology | journal | 1.076 Q1 | 104 | 102 | 333 | 4271 | 847 | 302 | 2.62 | 41.87 | 27.89 | |
31 | Cancer Molecular Biology | journal | 0.100 Q4 | 4 | 13 | 39 | 541 | 1 | 39 | 0.04 | 41.62 | 50.00 | |
32 | Cancer journal (Sudbury, Mass.) | journal | 1.148 Q1 | 102 | 90 | 279 | 3702 | 615 | 211 | 1.94 | 41.13 | 26.09 | |
33 | Nutrition and Cancer | journal | 0.879 Q1 | 130 | 99 | 291 | 4035 | 777 | 286 | 2.49 | 40.76 | 38.60 | |
34 | Pigment Cell and Melanoma Research | journal | 0.973 Q1 | 120 | 51 | 165 | 2068 | 335 | 161 | 2.05 | 40.55 | 40.00 | |
35 | Urologic Oncology: Seminars and Original Investigations | journal | 0.302 Q3 | 85 | 84 | 195 | 3307 | 292 | 171 | 1.32 | 39.37 | 14.35 | |
36 | Ca-A Cancer Journal for Clinicians | journal | 9.125 Q1 | 211 | 34 | 100 | 1316 | 1595 | 72 | 19.03 | 38.71 | 38.33 | |
37 | Cancer Research | journal | 4.432 Q1 | 498 | 1377 | 3054 | 53308 | 27535 | 3036 | 8.60 | 38.71 | 31.90 | |
38 | Nowotwory | journal | 0.107 Q4 | 11 | 16 | 47 | 601 | 5 | 47 | 0.08 | 37.56 | 40.48 | |
39 | Journal of Psychosocial Oncology | journal | 0.282 Q3 | 52 | 20 | 53 | 749 | 35 | 52 | 0.64 | 37.45 | 68.89 | |
40 | Clinical Cancer Research | journal | 2.121 Q1 | 377 | 605 | 1599 | 22457 | 8468 | 1549 | 5.08 | 37.12 | 30.52 | |
41 | Seminars in Oncology | journal | 1.345 Q1 | 145 | 241 | 688 | 8904 | 2839 | 650 | 3.91 | 36.95 | 26.61 | |
42 | Psycho-Oncology | journal | 1.048 Q1 | 158 | 53 | 163 | 1949 | 384 | 150 | 2.00 | 36.77 | 53.97 | |
43 | Tumor Diagnostik und Therapie | journal | 0.109 Q4 | 6 | 13 | 78 | 477 | 12 | 75 | 0.12 | 36.69 | 4.88 | |
44 | Cancer Immunology, Immunotherapy | journal | 0.988 Q1 | 136 | 76 | 257 | 2764 | 638 | 257 | 2.37 | 36.37 | 32.14 | |
45 | Current Treatment Options in Oncology | journal | 0.101 Q4 | 66 | 53 | 52 | 1912 | 2 | 52 | 0.04 | 36.08 | 20.39 | |
46 | International Journal of Cancer | journal | 1.815 Q1 | 260 | 691 | 2198 | 24711 | 9305 | 2125 | 4.24 | 35.76 | 29.48 | |
47 | Cancer Causes and Control | journal | 1.335 Q1 | 147 | 113 | 275 | 4033 | 869 | 247 | 2.76 | 35.69 | 45.06 | |
48 | Current Oncology Reports | journal | 0.201 Q3 | 77 | 75 | 112 | 2654 | 44 | 110 | 0.39 | 35.39 | 17.59 | |
49 | International Journal of Biological Markers | journal | 0.576 Q2 | 47 | 36 | 142 | 1259 | 197 | 120 | 1.29 | 34.97 | 41.67 | |
50 | Libri Oncologici | journal | 0.103 Q4 | 4 | 9 | 6 | 314 | 0 | 6 | 0.00 | 34.89 | 41.38 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®